EPHX2 and liver disorder: We did not analyse expression of sEH directly, therefore there is a possibility of increased sEH expression, as described in an animal models of high fat diet induced liver disease (López-Vicario et al., 2015) which might compensate for an inhibitory effect of sorafenib.